HF
ABBV icon

HRT Financial’s AbbVie ABBV Stock Holding History

HRT Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75M Buy
297,900
+216,000
+264% +$46.5M 0.14% 124
2026
Q1 		$17.8M Buy
81,900
+45,800
+127% +$10.2M 0.04% 378
2025
Q4 		$8.25M Sell
36,100
-24,700
-41% -$5.63M 0.03% 538
2025
Q3 		$14.1M Buy
60,800
+33,900
+126% +$6.9M 0.05% 278
2025
Q2 		$4.99M Buy
26,900
+19,000
+241% +$3.53M 0.02% 537
2025
Q1 		$1.66M Sell
7,900
-3,800
-32% -$739K 0.01% 896
2024
Q4 		$2.08M Buy
+11,700
New +$2.15M 0.01% 724
2021
Q1 		– Sell
-24,000
Closed -$2.57M – 2622
2020
Q4 		$2.57M Buy
+24,000
New +$2.31M 0.05% 277

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HRT Financial's ABBV Position: Q2 2026 in Review

HRT Financial reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $48.1M and leaving 702,907 shares worth $177M. The position accounts for 0.32% of the portfolio, ranked #38.

HRT Financial first reported a position in ABBV in Q4 2014 and has held it in 20 quarters since. The position peaked at $201M in Q1 2026. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HRT Financial held 702,907 shares of AbbVie worth $177M as of Q2 2026.
  • HRT Financial sold 223,503 AbbVie shares in Q2 2026, an estimated $48.1M.
  • AbbVie made up 0.32% of HRT Financial's portfolio in Q2 2026, its #38 holding.
  • HRT Financial first reported a position in AbbVie in Q4 2014 and has held it in 20 quarters since.
  • HRT Financial's AbbVie position peaked at $201M in Q1 2026.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.